DE69709349D1 - Arzneimittel bestehend aus diclofenac - Google Patents

Arzneimittel bestehend aus diclofenac

Info

Publication number
DE69709349D1
DE69709349D1 DE69709349T DE69709349T DE69709349D1 DE 69709349 D1 DE69709349 D1 DE 69709349D1 DE 69709349 T DE69709349 T DE 69709349T DE 69709349 T DE69709349 T DE 69709349T DE 69709349 D1 DE69709349 D1 DE 69709349D1
Authority
DE
Germany
Prior art keywords
diclofenac
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69709349T
Other languages
English (en)
Other versions
DE69709349T2 (de
Inventor
Alberto Reiner
Giorgio Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APR Applied Pharma Research SA
Original Assignee
APR Applied Pharma Research SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APR Applied Pharma Research SA filed Critical APR Applied Pharma Research SA
Application granted granted Critical
Publication of DE69709349D1 publication Critical patent/DE69709349D1/de
Publication of DE69709349T2 publication Critical patent/DE69709349T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69709349T 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac Expired - Lifetime DE69709349T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000992A IT1283029B1 (it) 1996-05-17 1996-05-17 Composizioni farmaceutiche a base di diclofenac
PCT/EP1997/002709 WO1997044023A1 (en) 1996-05-17 1997-05-15 Pharmaceutical compositions based on diclofenac

Publications (2)

Publication Number Publication Date
DE69709349D1 true DE69709349D1 (de) 2002-01-31
DE69709349T2 DE69709349T2 (de) 2002-07-25

Family

ID=11374276

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69709349T Expired - Lifetime DE69709349T2 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac
DE69718077T Expired - Lifetime DE69718077T2 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus Diclofenac

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69718077T Expired - Lifetime DE69718077T2 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus Diclofenac

Country Status (24)

Country Link
EP (2) EP0906092B1 (de)
KR (1) KR100441179B1 (de)
AR (1) AR007165A1 (de)
AT (2) ATE229801T1 (de)
AU (1) AU733083B2 (de)
CA (1) CA2254144C (de)
DE (2) DE69709349T2 (de)
DK (2) DK1159960T3 (de)
EE (1) EE9800400A (de)
ES (2) ES2187489T3 (de)
HK (1) HK1043939B (de)
HR (1) HRP970269A2 (de)
IT (1) IT1283029B1 (de)
LT (1) LT4530B (de)
LV (1) LV12250B (de)
MA (1) MA24183A1 (de)
NZ (1) NZ332655A (de)
PL (1) PL188883B1 (de)
PT (2) PT906092E (de)
SK (1) SK157698A3 (de)
TW (1) TW505525B (de)
WO (1) WO1997044023A1 (de)
YU (1) YU19797A (de)
ZA (1) ZA974270B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687542B2 (en) 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
EP1750677B1 (de) 2004-05-28 2017-02-01 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
US7700125B2 (en) 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
EP2480212B1 (de) * 2009-09-25 2016-07-06 Novartis Consumer Health S.A. Orale pharmazeutische Zusammensetzung mit Diclofenac
US11957792B2 (en) 2012-04-19 2024-04-16 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
US20180153835A1 (en) * 2015-06-05 2018-06-07 Lupin Limited Compositions of diclofenac acid
IT201700009711A1 (it) 2017-01-30 2018-07-30 Applied Pharma Res Sodium free Diclofenac potassium oral solutions Soluzioni orali di Diclofenac potassico prive di sodio
WO2020121277A1 (en) 2018-12-14 2020-06-18 Apr Applied Pharma Research, S.A. Ready to use diclofenac stick packs
EP4164612A1 (de) 2020-06-10 2023-04-19 Apr Applied Pharma Research S.A. Bioverfügbare diclofenac-formulierungen auf zuckerbasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung
EP0466650A2 (de) * 1990-07-11 1992-01-15 Warner-Lambert Company Entzündungshemmende Behandlung mit nichtsteroiden Mitteln
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
EP0642784B1 (de) * 1993-09-07 1999-05-19 Gerhard Dr. Gergely Brausemischung mit Alkalisalzen oder Lysinaten saurer, unlöslicher oder schwer löslicher Wirkstoffe
AU2531295A (en) * 1994-05-27 1995-12-21 Farmarc Nederland Bv Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs

Also Published As

Publication number Publication date
EE9800400A (et) 1999-06-15
DE69718077T2 (de) 2003-09-11
LV12250B (en) 1999-09-20
ZA974270B (en) 1998-01-30
CA2254144C (en) 2007-11-20
KR20000010792A (ko) 2000-02-25
ITMI960992A1 (it) 1997-11-17
PL188883B1 (pl) 2005-05-31
LT98160A (en) 1999-03-25
EP0906092B1 (de) 2001-12-19
NZ332655A (en) 2000-04-28
ES2187489T3 (es) 2003-06-16
KR100441179B1 (ko) 2004-11-26
DK1159960T3 (da) 2003-03-31
LT4530B (lt) 1999-07-26
YU19797A (sh) 1999-07-28
WO1997044023A1 (en) 1997-11-27
IT1283029B1 (it) 1998-04-03
AU3167697A (en) 1997-12-09
DE69709349T2 (de) 2002-07-25
DK0906092T3 (da) 2002-04-15
ATE210976T1 (de) 2002-01-15
ES2170396T3 (es) 2002-08-01
TW505525B (en) 2002-10-11
AU733083B2 (en) 2001-05-03
LV12250A (lv) 1999-04-20
HK1043939A1 (en) 2002-10-04
PT1159960E (pt) 2003-03-31
SK157698A3 (en) 2000-11-07
HRP970269A2 (en) 1998-04-30
EP1159960B1 (de) 2002-12-18
EP1159960A1 (de) 2001-12-05
PL329919A1 (en) 1999-04-26
EP0906092A1 (de) 1999-04-07
ITMI960992A0 (de) 1996-05-17
DE69718077D1 (de) 2003-01-30
AR007165A1 (es) 1999-10-13
ATE229801T1 (de) 2003-01-15
CA2254144A1 (en) 1997-11-27
HK1043939B (zh) 2003-05-16
PT906092E (pt) 2002-06-28
MA24183A1 (fr) 1997-12-31

Similar Documents

Publication Publication Date Title
ATE187063T1 (de) Arzneimittel
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
FI954402A0 (fi) Uusi farmaseuttinen tuote
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
DE69530325D1 (de) Aerosol-arzneiformulierungen
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
DE69737936D1 (de) Arzneimittel
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
BR9610396A (pt) Formulação farmacêutica
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
DE69430580D1 (de) Arzneimittel in nahrungsmittelform
DE69709349D1 (de) Arzneimittel bestehend aus diclofenac
DE69820861D1 (de) Teilchenförmige arzneimittelträger
ID16781A (id) Formulasi-formulasi farmasi
TR199501082A2 (tr) Farmasötik formülasyonlar.
ITMI941169A0 (it) Formulazioni farmaceutiche
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
NO950950D0 (no) Farmasöytisk preparat
BR9711981A (pt) Produto farmac-utico cristalino
DE59805373D1 (de) Nephroprotektive Arzneimittel
DE69819203D1 (de) Trinkbares arzneimittel
BR9603673A (pt) Preparado de combinação farmacêutica compreendendo cetoprofeno

Legal Events

Date Code Title Description
8364 No opposition during term of opposition